Kadans expands its presence in the United Kingdom by adding its second research hub in the country to its Pan-European science park portfolio.
Kadans acquired Sycamore House from GSK. It is a 9,640 sqm industrial and warehouse building, located directly adjacent to Stevenage Bioscience Catalyst (“SBC”), and the Cell and Gene Therapy Catapult Manufacturing Centre (“CGTCMC”). Kadans will redevelop and extend Sycamore House into a modern, vibrant, multi-tenanted R&D facility with expected completion mid-2021.
The building will provide grow-on space for overflowing demand from SBC and CGTCMC…
CAMBRIDGE, UK, 09 August 2019 – Start Codon, a new model of life science and healthcare business accelerator, today announced it has partnered with Clustermarket, a leading online equipment sharing and booking platform and Science Entrepreneur Club, a life sciences network, to help drive the translation of world-class life science and healthcare research into commercially successful companies. As part of the agreement, Start Codon will be co-sponsoring the Connect2Innovate Meetup on Tuesday 13th August 2019, 18:00-21:00 at The Bradfield Centre, Cambridge.
Founded in April 2019, Start Codon…
This transaction increases BioIVT’s portfolio of disease-state plasma, sera and controls, and enhances its ability to support the in vitro diagnostic market
Westbury, NY – Aug. 6, 2019 – BioIVT, a leading provider of research models and services for drug and diagnostic development, today announced that it has acquired Keystone Biologicals, Inc., a supplier of disease-state plasma, sera and controls, located in Hatboro, PA. This acquisition will expand BioIVT’s disease-state portfolio both by volume and product range.
“With the addition of Keystone Biologicals, BioIVT broadens its product…
This Transaction Increases BioIVT’s Portfolio of Disease-State Plasma, Sera and Controls, and Enhances its Ability to Support the In Vitro Diagnostic Market
Westbury, NY – Aug. 6, 2019 – BioIVT, a leading provider of research models and services for drug and diagnostic development, today announced that it has acquired Keystone Biologicals, Inc., a supplier of disease-state plasma, sera and controls, located in Hatboro, PA. This acquisition will expand BioIVT’s disease-state portfolio both by volume and product range.“With the addition of Keystone Biologicals, BioIVT broadens its…
Cambridge, UK, 6th August 2019: Arecor Limited (“Arecor” or “the Company”), the specialty pharmaceutical company leveraging its innovative and proprietary formulation technology to develop superior treatments for a range of disease areas, including diabetes, welcomed Mrs Kemi Badenoch, MP for Saffron Walden, to its offices at Chesterford Research Park.Arecor’s Chief Executive Officer, Dr Sarah Howell and Chief Financial Officer, Susan Lowther, met with Mrs Badenoch MP, to discuss the current climate for small companies in the UK healthcare industry.They covered a wide range of topics from the…
Lonza Signs 15-year Lease of the 42,000 sq ft Gonville Building at Chesterford Research Park
Cambridge, UK, 06 August 2019: Chesterford Research Park is delighted to welcome Lonza to Chesterford Research Park.The Swiss multinational CDMO, which provides contract development and manufacturing services to the pharmaceutical and biotech industries, has signed a 15-year lease of the 42,000 sq ft Gonville building, an impressive two-winged building, linked by a central reception block. Situated at the heart of the Park and within easy reach of The Nucleus central facilities building, the…
Precision for Medicine Launches Biospecimen Solutions Offering with Acquisition of ProMedDx and GLAS
BETHESDA, MD – August 1, 2019 – Precision for Medicine, part of Precision Medicine Group, announced it has acquired leading biospecimen providers ProMedDx and GLAS, significantly expanding its capabilities and expertise in the biospecimen solutions space. With the acquisitions, Precision now offers an unmatched level of scientific understanding, high-quality specimen solutions, and global scale.The addition of ProMedDx and GLAS establishes an unrivalled biospecimen solutions platform within Precision, which operates one of the largest biorepositories in the world. ProMedDx is known throughout…
Stevenage Bioscience Catalyst (SBC), a leading location for development and commercialisation of cutting-edge therapeutics, is pleased to announce that James Keeling has been appointed as Chief Financial Officer (CFO).
James joins from JGK Financial Management, a company set up to support SMEs in their growth phase providing expertise in business & financial planning, funding, sustainable investments and exit strategies. This has included working with business based in Loughborough University Science, Enterprise Park and as Interim CFO for Stevenage Bioscience Catalyst.
Prior to founding…
Cambridge, UK: 31st July 2019
ONE NUCLEUS STRENGTHENS BOARD WITH APPOINTMENT OF NEW DIRECTOR
Life Sciences industry company operations and communications expert joins the region’s Life Science & Healthcare membership organisation
One Nucleus, the Cambridge based not-for-profit membership organisation for the East of England and London life sciences cluster, is delighted to announce the appointment of Rowena Gardner as a Non-Executive Director. Rowena is currently VP Operations and Company Secretary for Microbiotica.Rowena’s…